Projects per year
Personal profile
Education
- 2000-2007 Ph.D., Graduate Institute of Medicine, Taipei Medical University
- 1995-1998 M.S., Graduate institute of Medicine, Taipei Medical University
- 1983-1990 M.D., School of Medicine, Taipei Medical University
Experience
- 2021.11- Professor, Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University
- 2021.11- Professor, Department of Urology, School of Medicine, College of Medicine, Taipei Medical University
- 2020.08 -2022.01 Vice Director, Research Center of Urology and Kidney, Taipei Medical University
- 2016.11- Director, Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University
- 2014.08- Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University
- 2014.08-2017.01 Director, Department of Urology, School of Medicine, Taipei Medical University
- 2014.02-2021.10 Professor, Department of Urology, School of Medicine, Taipei Medical University
- 2010.02-2014.01 Associate Professor, Department of Urology, School of Medicine, Taipei Medical University
- 2007.02+-2010.01 Assistant Professor, Department of Urology, School of Medicine, Taipei Medical University
- 1998.08-2007.01 Instructor, Department of Urology, School of Medicine, Taipei Medical University
- 1995.07- Attending Physician, Taipei Medical University Hospital
- 1994.07-1995.06 Researcher, Taipei Medical University Hospital
- 1990.07-1994.06 Resident Physician, Taipei Medical University Hospital
Research Interests
- Prostate hyperplasia, prostate cancer
- Genitourinary cancer
- Urinary indicative surgery in Teaching Hospital Accreditation
- Reproductive medicine
- General urinary system diseases
Fingerprint
Dive into the research topics where Kuan-Chou Chen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
甲基乙二醛經ChREBP/SREBP1造成腎小管脂毒性進而調控PGC1/SIRT3導致電子傳遞鏈缺陷之糖尿腎病進展-探討水飛薊素(Silybin)合併Metformin之逆轉潛能
8/1/21 → 7/31/22
Project: A - Government Institution › b - Ministry of Science and Technology
-
開發預測高風險前列腺癌發生的生物標記及分子機轉
1/1/21 → 12/31/21
Project: B - Project of TMU › h - Higher Education Sprout Project
-
探討黃腐醇合併降血糖藥是否可調控粒線體失常並經由活化未摺疊蛋白反應所激發之AMPK-NRf2-ARE-Glo1路徑來逆轉雙羰基壓力導致之糖尿病腎脂毒性
8/1/20 → 7/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
-
In Vi Vo and in Vi Tro Screening of the Dyslipidemic Antihypertensives, Studying the Mechanism to Modulate Signaling Srebp and Ppar in the Renal Cells, and Investigating the Cotherapy with Mountain Celery Seed Aqueous Extract in Reducing Worsen Renal F(3/3)
8/1/18 → 7/1/19
Project: A - Government Institution › b - Ministry of Science and Technology
-
In Vi Vo and in Vi Tro Screening of the Dyslipidemic Antihypertensives, Studying the Mechanism to Modulate Signaling Srebp and Ppar in the Renal Cells, and Investigating the Cotherapy with Mountain Celery Seed Aqueous Extract in Reducing Worsen Renal F
8/1/17 → 7/31/18
Project: A - Government Institution › b - Ministry of Science and Technology
-
Bicalutamide exhibits potential to damage kidney via destroying complex i and affecting mitochondrial dynamics
Chen, K. C., Chen, C. R., Chen, C. Y., Peng, C. C. & Peng, R. Y., Jan 1 2022, In: Journal of Clinical Medicine. 11, 1, 135.Research output: Contribution to journal › Article › peer-review
Open Access -
Bicalutamide may enhance kidney injury in diabetes by concomitantly damaging energy production from OXPHOS and glycolysis
Peng, C. C., Chen, C. R., Chen, C. Y., Chen, K. C. & Peng, R. Y., Apr 1 2022, In: Chemico-Biological Interactions. 356, 109858.Research output: Contribution to journal › Article › peer-review
-
The ADAM9/UBN2/AKR1C3 axis promotes resistance to androgen-deprivation in prostate cancer
Le, T. T-H., Hsieh, C-L., Lin, I-H., Chu, C-Y., Do, A. D., Chen, S-H., Shigemura, K., Kitagawa, K., Fujisawa, M., Liu, M-C., Chen, K-C. & Sung, S-Y., 2022, In: American Journal of Cancer Research. 12, 1, p. 176-197 22 p.Research output: Contribution to journal › Article › peer-review
-
Differential but concerted expression of HSD17B2, HSD17B3, SHBG and SRD5A1 testosterone tetrad modulate therapy response and susceptibility to disease relapse in patients with prostate cancer
Bamodu, O. A., Tzou, K. Y., Lin, C. D., Hu, S. W., Wang, Y. H., Wu, W. L., Chen, K. C. & Wu, C. C., Jul 2 2021, In: Cancers. 13, 14, 3478.Research output: Contribution to journal › Article › peer-review
Open Access -
Genetic suppressor element 1 (GSE1) promotes the oncogenic and recurrent phenotypes of castration-resistant prostate cancer by targeting tumor-associated calcium signal transducer 2 (TACSTD2)
Bamodu, O. A., Wang, Y. H., Ho, C. H., Hu, S. W., Lin, C. D., Tzou, K. Y., Wu, W. L., Chen, K. C. & Wu, C. C., Aug 2 2021, In: Cancers. 13, 16, 3959.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus)
Datasets
-
Data for: Enhanced uropathogenic Escherichia coli-induced infection in uroepithelial cells by sugar through TLR-4 and JAK/STAT1 signaling pathways
Cheng, P. (Contributor), Liu, H. (Contributor), Ho, C. (Contributor), Wu, C. (Contributor), Fan, C. (Contributor), Chen, K. (Contributor), Liu, S. (Contributor) & Yu, H. (Contributor), Unknown Publisher, Jul 9 2019
DOI: 10.17632/n25dwn3zjj.1, https://data.mendeley.com/datasets/n25dwn3zjj
Dataset